Report for: Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose

エビリファイは少量で抗うつ薬、高用量で抗精神病薬として作用するが、CBDも同じD2パーシャルアゴニストなので抗うつ薬として使用するには少量の方がいい。 https://t.co/mbN8MB00eq

pic ref. Figure 3 Int J Mol Sci. 2019 Jul; 20(13): 3314. ref. https://t.co/OOpj7H2Yav https://t.co/JYorkuFGYk

@USATODAY @dunkindonuts pm me i have ideas on how to reduce murders by cops dramatically https://t.co/nxe6lWm8Mm

@Peter_Grinspoon Don’t forget this one from the guy who discovered d2 receptors. https://t.co/2u06WSd55o

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose. https://t.co/0NDrXooIiE #CBD #hemp #cannabidiol

カンナビジオールは、ドーパミンD2High受容体の部分アゴニストであり、その抗精神病薬の臨床用量を予測します。 https://t.co/Qx5XdW0m2v https://t.co/0NDrXo77r6 #ヘンプ論文 #統合失調症

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/MRwJNsooxu

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose... https://t.co/O3t4k9sbUU

RT @ILMCPP: Recent reports showed that cannabidiol alleviated the signs and symptoms of schizophrenia. https://t.co/FSYASBX1WG

Recent reports showed that cannabidiol alleviated the signs and symptoms of schizophrenia. https://t.co/FSYASBX1WG

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose #CBD $GWPH https://t.co/TLt9rySHDc

Very important facts about CBD to treat Schizophrenia and why it is so antipsychotic:... https://t.co/Ht0PKo7Kzy

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/4kKu0mPnsb